Cansino Biologics Price To Book vs. Revenue
| 688185 Stock | 58.58 1.63 2.71% |
For Cansino Biologics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Cansino Biologics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Cansino Biologics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Cansino Biologics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Cansino Biologics over time as well as its relative position and ranking within its peers.
Cansino |
Cansino Biologics Revenue vs. Price To Book Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Cansino Biologics's current stock value. Our valuation model uses many indicators to compare Cansino Biologics value to that of its competitors to determine the firm's financial worth. Cansino Biologics is number one stock in price to book category among its peers. It also is the top company in revenue category among its peers totaling about 115,268,149 of Revenue per Price To Book. At present, Cansino Biologics' Total Revenue is projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all model that can be used if you cannot value Cansino Biologics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cansino Biologics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Cansino Revenue vs. Price To Book
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Cansino Biologics |
| = | 2.99 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Cansino Biologics |
| = | 345.18 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Cansino Revenue vs Competition
Cansino Biologics is the top company in revenue category among its peers. Market size based on revenue of Health Care industry is presently estimated at about 8.29 Trillion. Cansino Biologics adds roughly 345.18 Million in revenue claiming only tiny portion of equities under Health Care industry.
Cansino Biologics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Cansino Biologics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Cansino Biologics will eventually generate negative long term returns. The profitability progress is the general direction of Cansino Biologics' change in net profit over the period of time. It can combine multiple indicators of Cansino Biologics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 35.7 M | 27.1 M | |
| Interest Income | 100.1 M | 105.1 M | |
| Operating Income | -2.1 B | -2 B | |
| Net Loss | -2 B | -1.9 B | |
| Income Before Tax | -2 B | -1.9 B | |
| Net Loss | -1 B | -993.6 M | |
| Net Loss | -1.4 B | -1.4 B | |
| Income Tax Expense | -197.3 M | -187.5 M | |
| Change To Netincome | 944.4 M | 991.7 M |
Cansino Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Cansino Biologics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Cansino Biologics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Cansino Biologics' important profitability drivers and their relationship over time.
Use Cansino Biologics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cansino Biologics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cansino Biologics will appreciate offsetting losses from the drop in the long position's value.Cansino Biologics Pair Trading
Cansino Biologics Pair Trading Analysis
The ability to find closely correlated positions to Cansino Biologics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cansino Biologics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cansino Biologics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cansino Biologics to buy it.
The correlation of Cansino Biologics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cansino Biologics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cansino Biologics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cansino Biologics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Cansino Biologics position
In addition to having Cansino Biologics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Real Estate ETFs Thematic Idea Now
Real Estate ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Real Estate ETFs theme has 65 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Real Estate ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Cansino Stock
To fully project Cansino Biologics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Cansino Biologics at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Cansino Biologics' income statement, its balance sheet, and the statement of cash flows.